Cytomegalovirus (CMV) Tests Market, By Sample Type, By Drug Type, By Test Type, By End User, By Application, By Country, and By Region - Industry Analysis, Market Size, Market Share & Forecast from 2024-2032

Description

REPORT HIGHLIGHT

Cytomegalovirus (CMV) Tests Market size was valued at USD 49.90 Million in 2023, expanding at a CAGR of 1.01% from 2024 to 2032.

Cytomegalovirus (CMV) tests are diagnostic tools designed to identify the presence of CMV, a widespread virus that can lead to serious health complications, particularly in immunocompromised individuals and newborns. These tests often utilize laboratory techniques, including polymerase chain reaction (PCR) for detecting viral DNA, as well as serological methods to identify the antibodies against CMV. Early detection is vital for managing potential complications, such as congenital CMV infection in infants or opportunistic infections in transplant recipients. Accurate testing enables timely intervention and monitoring, making CMV testing a critical aspect of healthcare for at-risk populations.

Cytomegalovirus (CMV) Tests Market- Market Dynamics

Increasing incidence prevalence of the CMV infections, increased awareness about virus, and the development of new and more effective treatment options to propel market demand

Most physicians recommend cytomegalovirus (CMV) tests for patients with suspected fetal abnormalities or recurrent miscarriages, contributing to market growth. CMV tests are essential for detecting this virus, which can lead to serious illnesses in immunocompromised individuals and infants. As a widely distributed pathogen, CMV is the leading cause of congenital infections globally. It is a human herpesvirus that can be transmitted through intimate contact with infected bodily fluids, as well as via transplacental transfer, blood transfusions, or organ transplants. The CMV treatment market is propelled by several factors, including the rising prevalence of CMV infections, increased awareness about the virus, and the development of new and more effective treatment options. Common CMV treatments include antiviral medications, immunoglobulin therapy, and stem cell transplantation. This market is further driven by the growing incidence of chronic diseases, the demand for personalized medicine, and the increasing availability of treatments in developing countries. According to an August 2023 article published by the National Library of Medicine, approximately 59% of individuals over six years old have encountered CMV, with seroprevalence increasing with age. CMV infections can manifest as primary infections, reinfections, or reactivations, occurring through various transmission modes such as blood products, breastfeeding, close-contact settings, perinatal transmission, and sexual contact. Reactivation is particularly concerning in immunocompromised patients, as it is associated with increased morbidity and mortality. For individuals with intact immunity, CMV rarely results in death; however, in immunocompromised patients undergoing chemotherapy or taking corticosteroids, it can lead to significant health issues. Following bone marrow transplants, reported mortality rates related to CMV vary between 10% and 75%, further boosting the CMV treatment market. Moreover, CMV infects approximately 60% to 70% of adults in industrialized countries and nearly 100% in emerging countries. Among herpesviruses, CMV has the largest number of genes specifically designed to evade both innate and adaptive immune responses. This virus poses a burden on T-cell antigenic surveillance and contributes to immune dysfunction. Additionally, congenital CMV is a primary infectious cause of learning disabilities, deafness, and intellectual disabilities, making it a significant driver for the CMV treatment market.

Cytomegalovirus (CMV) Tests Market- Key Insights

As per the analysis shared by our research analyst, the global market is estimated to grow annually at a CAGR of around 1.01% over the forecast period (2024-2032)

Based on Test Type segmentation, nucleic acid amplification tests (NAATs) was predicted to show maximum market share in the year 2023

Based on Drug Type segmentation, Valganciclovir was the leading type in 2023

On the basis of region, North America was the leading revenue generator in 2023

Cytomegalovirus (CMV) Tests Market- Segmentation Analysis:

The Global Cytomegalovirus (CMV) Tests Market is segmented on the basis of Sample Type, Drug Type, Test Type, End User, Application, and Region.

The market is divided into three categories based on Test Type: enzyme immunoassay/enzyme-linked immunosorbent assay (EIA/ELISA) tests, nucleic acid amplification tests (NAATs), and other CMV tests. Among these, the CMV nucleic acid amplification tests (NAATs) segment led the market share in 2023, primarily due to their high sensitivity and specificity in detecting viral DNA. NAATs are particularly advantageous in clinical settings because they enable early and accurate diagnosis of CMV infections, especially in immunocompromised patients, where timely intervention is critical to preventing severe complications.

The market is divided into five categories based on Drug Type: Valganciclovir, Ganciclovir, Cidofovir, Foscarnet and Others. In the cytomegalovirus (CMV) tests market, Valganciclovir stands out as the leading drug type, largely due to its oral bioavailability and effectiveness in preventing and treating CMV infections, especially in immunocompromised patients. Its ease of administration compared to intravenous alternatives like Ganciclovir enhances its popularity in clinical settings. Although Ganciclovir remains significant, particularly in acute situations, and other medications such as Cidofovir and Foscarnet are employed for resistant cases, Valganciclovir's proven efficacy and user-friendly administration make it the preferred option among healthcare professionals. This trend underscores a wider movement toward more patient-centric treatment solutions in managing CMV infections.

Cytomegalovirus (CMV) Tests Market- Geographical Insights

North America is the dominating region in the Cytomegalovirus (CMV) Tests market, primarily due to its advanced healthcare infrastructure, high prevalence of antibiotic-resistant infections, and significant investments in research and development. The region's hospitals are major consumers of these antibiotics, particularly Vancomycin, to manage serious Gram-positive infections like MRSA. Furthermore, supportive regulatory frameworks and a strong emphasis on infection control contribute to the growing demand for Cytomegalovirus (CMV) Tests. The presence of key pharmaceutical companies and ongoing clinical trials in this region further enhance its market leadership.

Cytomegalovirus (CMV) Tests Market- Competitive Landscape:

Companies in the CMV tests market adopt various strategies to strengthen their market presence and foster innovation. A primary focus is on investing in research and development to enhance the sensitivity and specificity of testing methods while creating rapid diagnostic solutions. Collaborations with healthcare providers and laboratories help streamline testing processes and gather insights into clinical needs. Marketing initiatives highlight the significance of early detection and management of CMV-related conditions, targeting healthcare professionals and institutions. Additionally, companies engage in educational campaigns to raise awareness about CMV risks, thereby expanding the market for their testing products and services.

Recent Developments:

In September 2022, ProBioGen entered into an agreement with the City of Hope to manufacture the CMV vaccine for clinical trials and commercial distribution, accelerating the development and production of the vaccine that could potentially save numerous lives.

SCOPE OF THE REPORT

The scope of this report covers the market by its major segments, which include as follows:

GLOBAL CYTOMEGALOVIRUS (CMV) TESTS MARKET KEY PLAYERS- DETAILED COMPETITIVE INSIGHTS

Pfizer Inc.
GlaxoSmithKline plc
Novartis AG
Mylan N.V.
Teva Pharmaceutical Industries Ltd.
Sanofi
F. Hoffmann-La Roche Ltd.
Zydus Cadila
Lupin
Cipla Inc.
Aurobindo Pharma
Glenmark Pharmaceuticals Limited
Endo International plc
AstraZeneca
Johnson & Johnson Private Limited
Bio-Rad Laboratories, Inc.
BD
Others

GLOBAL CYTOMEGALOVIRUS (CMV) TESTS MARKET, BY SAMPLE TYPE- MARKET ANALYSIS, 2019 - 2032

Urine
Blood

GLOBAL CYTOMEGALOVIRUS (CMV) TESTS MARKET, BY DRUG TYPE- MARKET ANALYSIS, 2019 - 2032

Valganciclovir
Ganciclovir
Cidofovir
Foscarnet
Others

GLOBAL CYTOMEGALOVIRUS (CMV) TESTS MARKET, BY TEST TYPE- MARKET ANALYSIS, 2019 - 2032

Enzyme immunoassay/enzyme-linked immunosorbent assay (EIA/ELISA) tests
Nucleic acid amplification tests (NAATs)
Other CMV tests

GLOBAL CYTOMEGALOVIRUS (CMV) TESTS MARKET, BY END USER- MARKET ANALYSIS, 2019 - 2032

Hospitals
Diagnostic Centres
Clinics
Others

GLOBAL CYTOMEGALOVIRUS (CMV) TESTS MARKET, BY APPLICATION- MARKET ANALYSIS, 2019 - 2032

Retinitis
Pneumonia
Gastrointestinal ulcers
Encephalitis
Stem cell transplantation
Organ transplantation
Others (Mouth Ulcers, Pharyngitis, etc.)

GLOBAL CYTOMEGALOVIRUS (CMV) TESTS MARKET, BY REGION- MARKET ANALYSIS, 2019 - 2032

North America
The U.S.
Canada
Europe
Germany
France
Italy
Spain
United Kingdom
Russia
Netherlands
Sweden
Poland
Rest of Europe
Asia Pacific
India
China
South Korea
Japan
Australia
Thailand
Indonesia
Philippines
Rest of APAC
Latin America
Brazil
Mexico
Argentina
Colombia
Rest of LATAM
The Middle East and Africa
Saudi Arabia
United Arab Emirates
Israel
Turkey
Algeria
Egypt
Rest of MEA

Product Code: ANV4075

1. Cytomegalovirus (CMV) Tests Market Overview

1.1. Study Scope
1.2. Market Estimation Years

2. Executive Summary

2.1. Market Snippet
- 2.1.1. Cytomegalovirus (CMV) Tests Market Snippet by Sample Type
- 2.1.2. Cytomegalovirus (CMV) Tests Market Snippet by Drug Type
- 2.1.3. Cytomegalovirus (CMV) Tests Market Snippet by Test Type
- 2.1.4. Cytomegalovirus (CMV) Tests Market Snippet by End User
- 2.1.5. Cytomegalovirus (CMV) Tests Market Snippet by Application
- 2.1.6. Cytomegalovirus (CMV) Tests Market Snippet by Country
- 2.1.7. Cytomegalovirus (CMV) Tests Market Snippet by Region
2.2. Competitive Insights

3. Cytomegalovirus (CMV) Tests Key Market Trends

3.1. Cytomegalovirus (CMV) Tests Market Drivers
- 3.1.1. Impact Analysis of Market Drivers
3.2. Cytomegalovirus (CMV) Tests Market Restraints
- 3.2.1. Impact Analysis of Market Restraints
3.3. Cytomegalovirus (CMV) Tests Market Opportunities
3.4. Cytomegalovirus (CMV) Tests Market Future Trends

4. Cytomegalovirus (CMV) Tests Industry Study

4.1. PEST Analysis
4.2. Porter's Five Forces Analysis
4.3. Growth Prospect Mapping
4.4. Regulatory Framework Analysis

5. Cytomegalovirus (CMV) Tests Market: COVID-19 Impact Analysis

5.1. Pre-COVID-19 Impact Analysis
5.2. Post-COVID-19 Impact Analysis
- 5.2.1. Top Performing Segments
- 5.2.2. Marginal Growth Segments
- 5.2.3. Top Looser Segments
- 5.2.4. Marginal Loss Segments

6. Cytomegalovirus (CMV) Tests Market Landscape

6.1. Cytomegalovirus (CMV) Tests Market Share Analysis, 2023
6.2. Breakdown Data, by Key Manufacturer
- 6.2.1. Established Players' Analysis
- 6.2.2. Emerging Players' Analysis

7. Cytomegalovirus (CMV) Tests Market - By Sample Type

7.1. Overview
- 7.1.1. Segment Share Analysis, By Sample Type, 2023 & 2032 (%)
- 7.1.2. Urine
- 7.1.3. Blood

8. Cytomegalovirus (CMV) Tests Market - By Drug Type

8.1. Overview
- 8.1.1. Segment Share Analysis, By Drug Type, 2023 & 2032 (%)
- 8.1.2. Valganciclovir
- 8.1.3. Ganciclovir
- 8.1.4. Cidofovir
- 8.1.5. Foscarnet
- 8.1.6. Others

9. Cytomegalovirus (CMV) Tests Market - By Test Type

9.1. Overview
- 9.1.1. Segment Share Analysis, By Test Type, 2023 & 2032 (%)
- 9.1.2. Enzyme immunoassay/enzyme-linked immunosorbent assay (EIA/ELISA) tests
- 9.1.3. Nucleic acid amplification tests (NAATs)
- 9.1.4. Other CMV tests

10. Cytomegalovirus (CMV) Tests Market - By End User

10.1. Overview
- 10.1.1. Segment Share Analysis, By End User, 2023 & 2032 (%)
- 10.1.2. Hospitals
- 10.1.3. Diagnostic Centres
- 10.1.4. Clinics
- 10.1.5. Others

11. Cytomegalovirus (CMV) Tests Market - By Application

11.1. Overview
- 11.1.1. Segment Share Analysis, By Application, 2023 & 2032 (%)
- 11.1.2. Retinitis
- 11.1.3. Pneumonia
- 11.1.4. Gastrointestinal ulcers
- 11.1.5. Encephalitis
- 11.1.6. Stem cell transplantation
- 11.1.7. Organ transplantation
- 11.1.8. Others (Mouth Ulcers, Pharyngitis, etc.)

12. Cytomegalovirus (CMV) Tests Market- By Geography

12.1. Introduction
- 12.1.1. Segment Share Analysis, By Geography, 2023 & 2032 (%)
12.2. North America
- 12.2.1. Overview
- 12.2.2. Cytomegalovirus (CMV) Tests Key Manufacturers in North America
- 12.2.3. North America Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
- 12.2.4. North America Market Size and Forecast, By Sample Type, 2019 - 2032 (US$ Million)
- 12.2.5. North America Market Size and Forecast, By Drug Type, 2019 - 2032 (US$ Million)
- 12.2.6. North America Market Size and Forecast, By Test Type, 2019 - 2032 (US$ Million)
- 12.2.7. North America Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
- 12.2.8. North America Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
- 12.2.9. U.S.
  - 12.2.9.1. Overview
  - 12.2.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 12.2.9.3. U.S. Market Size and Forecast, By Sample Type, 2019 - 2032 (US$ Million)
  - 12.2.9.4. U.S. Market Size and Forecast, By Drug Type, 2019 - 2032 (US$ Million)
  - 12.2.9.5. U.S. Market Size and Forecast, By Test Type, 2019 - 2032 (US$ Million)
  - 12.2.9.6. U.S. Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
  - 12.2.9.7. U.S. Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
- 12.2.10. Canada
  - 12.2.10.1. Overview
  - 12.2.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 12.2.10.3. Canada Market Size and Forecast, By Sample Type, 2019 - 2032 (US$ Million)
  - 12.2.10.4. Canada Market Size and Forecast, By Drug Type, 2019 - 2032 (US$ Million)
  - 12.2.10.5. Canada Market Size and Forecast, By Test Type, 2019 - 2032 (US$ Million)
  - 12.2.10.6. Canada Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
  - 12.2.10.7. Canada Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
12.3. Europe
- 12.3.1. Overview
- 12.3.2. Cytomegalovirus (CMV) Tests Key Manufacturers in Europe
- 12.3.3. Europe Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
- 12.3.4. Europe Market Size and Forecast, By Sample Type, 2019 - 2032 (US$ Million)
- 12.3.5. Europe Market Size and Forecast, By Drug Type, 2019 - 2032 (US$ Million)
- 12.3.6. Europe Market Size and Forecast, By Test Type, 2019 - 2032 (US$ Million)
- 12.3.7. Europe Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
- 12.3.8. Europe Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
- 12.3.9. Germany
  - 12.3.9.1. Overview
  - 12.3.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 12.3.9.3. Germany Market Size and Forecast, By Sample Type, 2019 - 2032 (US$ Million)
  - 12.3.9.4. Germany Market Size and Forecast, By Drug Type, 2019 - 2032 (US$ Million)
  - 12.3.9.5. Germany Market Size and Forecast, By Test Type, 2019 - 2032 (US$ Million)
  - 12.3.9.6. Germany Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
  - 12.3.9.7. Germany Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
- 12.3.10. Italy
  - 12.3.10.1. Overview
  - 12.3.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 12.3.10.3. Italy Market Size and Forecast, By Sample Type, 2019 - 2032 (US$ Million)
  - 12.3.10.4. Italy Market Size and Forecast, By Drug Type, 2019 - 2032 (US$ Million)
  - 12.3.10.5. Italy Market Size and Forecast, By Test Type, 2019 - 2032 (US$ Million)
  - 12.3.10.6. Italy Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
  - 12.3.10.7. Italy Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
- 12.3.11. United Kingdom
  - 12.3.11.1. Overview
  - 12.3.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 12.3.11.3. United Kingdom Market Size and Forecast, By Sample Type, 2019 - 2032 (US$ Million)
  - 12.3.11.4. United Kingdom Market Size and Forecast, By Drug Type, 2019 - 2032 (US$ Million)
  - 12.3.11.5. United Kingdom Market Size and Forecast, By Test Type, 2019 - 2032 (US$ Million)
  - 12.3.11.6. United Kingdom Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
  - 12.3.11.7. United Kingdom Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
- 12.3.12. France
  - 12.3.12.1. Overview
  - 12.3.12.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 12.3.12.3. France Market Size and Forecast, By Sample Type, 2019 - 2032 (US$ Million)
  - 12.3.12.4. France Market Size and Forecast, By Drug Type, 2019 - 2032 (US$ Million)
  - 12.3.12.5. France Market Size and Forecast, By Test Type, 2019 - 2032 (US$ Million)
  - 12.3.12.6. France Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
  - 12.3.12.7. France Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
- 12.3.13. Russia
  - 12.3.13.1. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 12.3.13.2. Russia Market Size and Forecast, By Sample Type, 2019 - 2032 (US$ Million)
  - 12.3.13.3. Russia Market Size and Forecast, By Drug Type, 2019 - 2032 (US$ Million)
  - 12.3.13.4. Russia Market Size and Forecast, By Test Type, 2019 - 2032 (US$ Million)
  - 12.3.13.5. Russia Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
  - 12.3.13.6. Russia Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
- 12.3.14. Netherlands
  - 12.3.14.1. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 12.3.14.2. Netherlands Market Size and Forecast, By Sample Type, 2019 - 2032 (US$ Million)
  - 12.3.14.3. Netherlands Market Size and Forecast, By Drug Type, 2019 - 2032 (US$ Million)
  - 12.3.14.4. Netherlands Market Size and Forecast, By Test Type, 2019 - 2032 (US$ Million)
  - 12.3.14.5. Netherlands Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
  - 12.3.14.6. Netherlands Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
- 12.3.15. Sweden
  - 12.3.15.1. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 12.3.15.2. Sweden Market Size and Forecast, By Sample Type, 2019 - 2032 (US$ Million)
  - 12.3.15.3. Sweden Market Size and Forecast, By Drug Type, 2019 - 2032 (US$ Million)
  - 12.3.15.4. Sweden Market Size and Forecast, By Test Type, 2019 - 2032 (US$ Million)
  - 12.3.15.5. Sweden Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
  - 12.3.15.6. Sweden Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
- 12.3.16. Poland
  - 12.3.16.1. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 12.3.16.2. Poland Market Size and Forecast, By Sample Type, 2019 - 2032 (US$ Million)
  - 12.3.16.3. Poland Market Size and Forecast, By Drug Type, 2019 - 2032 (US$ Million)
  - 12.3.16.4. Poland Market Size and Forecast, By Test Type, 2019 - 2032 (US$ Million)
  - 12.3.16.5. Poland Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
  - 12.3.16.6. Poland Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
- 12.3.17. Rest of Europe
  - 12.3.17.1. Overview
  - 12.3.17.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 12.3.17.3. Rest of the Europe Market Size and Forecast, By Sample Type, 2019 - 2032 (US$ Million)
  - 12.3.17.4. Rest of the Europe Market Size and Forecast, By Drug Type, 2019 - 2032 (US$ Million)
  - 12.3.17.5. Rest of the Europe Market Size and Forecast, By Test Type, 2019 - 2032 (US$ Million)
  - 12.3.17.6. Rest of the Europe Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
  - 12.3.17.7. Rest of the Europe Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
12.4. Asia Pacific (APAC)
- 12.4.1. Overview
- 12.4.2. Cytomegalovirus (CMV) Tests Key Manufacturers in Asia Pacific
- 12.4.3. Asia Pacific Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
- 12.4.4. Asia Pacific Market Size and Forecast, By Sample Type, 2019 - 2032 (US$ Million)
- 12.4.5. Asia Pacific Market Size and Forecast, By Drug Type, 2019 - 2032 (US$ Million)
- 12.4.6. Asia Pacific Market Size and Forecast, By Test Type, 2019 - 2032 (US$ Million)
- 12.4.7. Asia Pacific Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
- 12.4.8. Asia Pacific Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
- 12.4.9. India
  - 12.4.9.1. Overview
  - 12.4.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 12.4.9.3. India Market Size and Forecast, By Sample Type, 2019 - 2032 (US$ Million)
  - 12.4.9.4. India Market Size and Forecast, By Drug Type, 2019 - 2032 (US$ Million)
  - 12.4.9.5. India Market Size and Forecast, By Test Type, 2019 - 2032 (US$ Million)
  - 12.4.9.6. India Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
  - 12.4.9.7. India Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
- 12.4.10. China
  - 12.4.10.1. Overview
  - 12.4.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 12.4.10.3. China Market Size and Forecast, By Sample Type, 2019 - 2032 (US$ Million)
  - 12.4.10.4. China Market Size and Forecast, By Drug Type, 2019 - 2032 (US$ Million)
  - 12.4.10.5. China Market Size and Forecast, By Test Type, 2019 - 2032 (US$ Million)
  - 12.4.10.6. China Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
  - 12.4.10.7. China Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
- 12.4.11. Japan
  - 12.4.11.1. Overview
  - 12.4.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 12.4.11.3. Japan Market Size and Forecast, By Sample Type, 2019 - 2032 (US$ Million)
  - 12.4.11.4. Japan Market Size and Forecast, By Drug Type, 2019 - 2032 (US$ Million)
  - 12.4.11.5. Japan Market Size and Forecast, By Test Type, 2019 - 2032 (US$ Million)
  - 12.4.11.6. Japan Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
  - 12.4.11.7. Japan Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
- 12.4.12. South Korea
  - 12.4.12.1. Overview
  - 12.4.12.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 12.4.12.3. South Korea Market Size and Forecast, By Sample Type, 2019 - 2032 (US$ Million)
  - 12.4.12.4. South Korea Market Size and Forecast, By Drug Type, 2019 - 2032 (US$ Million)
  - 12.4.12.5. South Korea Market Size and Forecast, By Test Type, 2019 - 2032 (US$ Million)
  - 12.4.12.6. South Korea Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
  - 12.4.12.7. South Korea Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
- 12.4.13. Australia
  - 12.4.13.1. Overview
  - 12.4.13.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 12.4.13.3. Australia Market Size and Forecast, By Sample Type, 2019 - 2032 (US$ Million)
  - 12.4.13.4. Australia Market Size and Forecast, By Drug Type, 2019 - 2032 (US$ Million)
  - 12.4.13.5. Australia Market Size and Forecast, By Test Type, 2019 - 2032 (US$ Million)
  - 12.4.13.6. Australia Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
  - 12.4.13.7. Australia Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
- 12.4.14. Thailand
  - 12.4.14.1. Overview
  - 12.4.14.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 12.4.14.3. Thailand Market Size and Forecast, By Sample Type, 2019 - 2032 (US$ Million)
  - 12.4.14.4. Thailand Market Size and Forecast, By Drug Type, 2019 - 2032 (US$ Million)
  - 12.4.14.5. Thailand Market Size and Forecast, By Test Type, 2019 - 2032 (US$ Million)
  - 12.4.14.6. Thailand Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
  - 12.4.14.7. Thailand Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
- 12.4.15. Indonesia
  - 12.4.15.1. Overview
  - 12.4.15.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 12.4.15.3. Indonesia Market Size and Forecast, By Sample Type, 2019 - 2032 (US$ Million)
  - 12.4.15.4. Indonesia Market Size and Forecast, By Drug Type, 2019 - 2032 (US$ Million)
  - 12.4.15.5. Indonesia Market Size and Forecast, By Test Type, 2019 - 2032 (US$ Million)
  - 12.4.15.6. Indonesia Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
  - 12.4.15.7. Indonesia Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
- 12.4.16. Philippines
  - 12.4.16.1. Overview
  - 12.4.16.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 12.4.16.3. Philippines Market Size and Forecast, By Sample Type, 2019 - 2032 (US$ Million)
  - 12.4.16.4. Philippines Market Size and Forecast, By Drug Type, 2019 - 2032 (US$ Million)
  - 12.4.16.5. Philippines Market Size and Forecast, By Test Type, 2019 - 2032 (US$ Million)
  - 12.4.16.6. Philippines Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
  - 12.4.16.7. Philippines Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
- 12.4.17. Rest of APAC
  - 12.4.17.1. Overview
  - 12.4.17.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 12.4.17.3. Rest of APAC Market Size and Forecast, By Sample Type, 2019 - 2032 (US$ Million)
  - 12.4.17.4. Rest of APAC Market Size and Forecast, By Drug Type, 2019 - 2032 (US$ Million)
  - 12.4.17.5. Rest of APAC Market Size and Forecast, By Test Type, 2019 - 2032 (US$ Million)
  - 12.4.17.6. Rest of APAC Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
  - 12.4.17.7. Rest of APAC Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
12.5. Latin America
- 12.5.1. Overview
- 12.5.2. Cytomegalovirus (CMV) Tests Key Manufacturers in Latin America
- 12.5.3. Latin America Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
- 12.5.4. Latin America Market Size and Forecast, By Sample Type, 2019 - 2032 (US$ Million)
- 12.5.5. Latin America Market Size and Forecast, By Drug Type, 2019 - 2032 (US$ Million)
- 12.5.6. Latin America Market Size and Forecast, By Test Type, 2019 - 2032 (US$ Million)
- 12.5.7. Latin America Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
- 12.5.8. Latin America Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
- 12.5.9. Brazil
  - 12.5.9.1. Overview
  - 12.5.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 12.5.9.3. Brazil Market Size and Forecast, By Sample Type, 2019 - 2032 (US$ Million)
  - 12.5.9.4. Brazil Market Size and Forecast, By Drug Type, 2019 - 2032 (US$ Million)
  - 12.5.9.5. Brazil Market Size and Forecast, By Test Type, 2019 - 2032 (US$ Million)
  - 12.5.9.6. Brazil Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
  - 12.5.9.7. Brazil Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
- 12.5.10. Mexico
  - 12.5.10.1. Overview
  - 12.5.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 12.5.10.3. Mexico Market Size and Forecast, By Sample Type, 2019 - 2032 (US$ Million)
  - 12.5.10.4. Mexico Market Size and Forecast, By Drug Type, 2019 - 2032 (US$ Million)
  - 12.5.10.5. Mexico Market Size and Forecast, By Test Type, 2019 - 2032 (US$ Million)
  - 12.5.10.6. Mexico Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
  - 12.5.10.7. Mexico Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
- 12.5.11. Argentina
  - 12.5.11.1. Overview
  - 12.5.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 12.5.11.3. Argentina Market Size and Forecast, By Sample Type, 2019 - 2032 (US$ Million)
  - 12.5.11.4. Argentina Market Size and Forecast, By Drug Type, 2019 - 2032 (US$ Million)
  - 12.5.11.5. Argentina Market Size and Forecast, By Test Type, 2019 - 2032 (US$ Million)
  - 12.5.11.6. Argentina Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
  - 12.5.11.7. Argentina Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
- 12.5.12. Colombia
  - 12.5.12.1. Overview
  - 12.5.12.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 12.5.12.3. Colombia Market Size and Forecast, By Sample Type, 2019 - 2032 (US$ Million)
  - 12.5.12.4. Colombia Market Size and Forecast, By Drug Type, 2019 - 2032 (US$ Million)
  - 12.5.12.5. Colombia Market Size and Forecast, By Test Type, 2019 - 2032 (US$ Million)
  - 12.5.12.6. Colombia Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
  - 12.5.12.7. Colombia Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
- 12.5.13. Rest of LATAM
  - 12.5.13.1. Overview
  - 12.5.13.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 12.5.13.3. Rest of LATAM Market Size and Forecast, By Sample Type, 2019 - 2032 (US$ Million)
  - 12.5.13.4. Rest of LATAM Market Size and Forecast, By Drug Type, 2019 - 2032 (US$ Million)
  - 12.5.13.5. Rest of LATAM Market Size and Forecast, By Test Type, 2019 - 2032 (US$ Million)
  - 12.5.13.6. Rest of LATAM Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
  - 12.5.13.7. Rest of LATAM Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
12.6. Middle East and Africa
- 12.6.1. Overview
- 12.6.2. Cytomegalovirus (CMV) Tests Key Manufacturers in Middle East and Africa
- 12.6.3. Middle East and Africa Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
- 12.6.4. Middle East and Africa Market Size and Forecast, By Sample Type, 2019 - 2032 (US$ Million)
- 12.6.5. Middle East and Africa Market Size and Forecast, By Drug Type, 2019 - 2032 (US$ Million)
- 12.6.6. Middle East and Africa Market Size and Forecast, By Test Type, 2019 - 2032 (US$ Million)
- 12.6.7. Middle East and Africa Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
- 12.6.8. Middle East and Africa Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
- 12.6.9. Saudi Arabia
  - 12.6.9.1. Overview
  - 12.6.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 12.6.9.3. Saudi Arabia Market Size and Forecast, By Sample Type, 2019 - 2032 (US$ Million)
  - 12.6.9.4. Saudi Arabia Market Size and Forecast, By Drug Type, 2019 - 2032 (US$ Million)
  - 12.6.9.5. Saudi Arabia Market Size and Forecast, By Test Type, 2019 - 2032 (US$ Million)
  - 12.6.9.6. Saudi Arabia Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
  - 12.6.9.7. Saudi Arabia Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
- 12.6.10. United Arab Emirates
  - 12.6.10.1. Overview
  - 12.6.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 12.6.10.3. United Arab Emirates Market Size and Forecast, By Sample Type, 2019 - 2032 (US$ Million)
  - 12.6.10.4. United Arab Emirates Market Size and Forecast, By Drug Type, 2019 - 2032 (US$ Million)
  - 12.6.10.5. United Arab Emirates Market Size and Forecast, By Test Type, 2019 - 2032 (US$ Million)
  - 12.6.10.6. United Arab Emirates Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
  - 12.6.10.7. United Arab Emirates Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
- 12.6.11. Israel
  - 12.6.11.1. Overview
  - 12.6.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 12.6.11.3. Israel Market Size and Forecast, By Sample Type, 2019 - 2032 (US$ Million)
  - 12.6.11.4. Israel Market Size and Forecast, By Drug Type, 2019 - 2032 (US$ Million)
  - 12.6.11.5. Israel Market Size and Forecast, By Test Type, 2019 - 2032 (US$ Million)
  - 12.6.11.6. Israel Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
  - 12.6.11.7. Israel Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
- 12.6.12. Turkey
  - 12.6.12.1. Overview
  - 12.6.12.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 12.6.12.3. Turkey Market Size and Forecast, By Sample Type, 2019 - 2032 (US$ Million)
  - 12.6.12.4. Turkey Market Size and Forecast, By Drug Type, 2019 - 2032 (US$ Million)
  - 12.6.12.5. Turkey Market Size and Forecast, By Test Type, 2019 - 2032 (US$ Million)
  - 12.6.12.6. Turkey Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
  - 12.6.12.7. Turkey Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
- 12.6.13. Algeria
  - 12.6.13.1. Overview
  - 12.6.13.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 12.6.13.3. Algeria Market Size and Forecast, By Sample Type, 2019 - 2032 (US$ Million)
  - 12.6.13.4. Algeria Market Size and Forecast, By Drug Type, 2019 - 2032 (US$ Million)
  - 12.6.13.5. Algeria Market Size and Forecast, By Test Type, 2019 - 2032 (US$ Million)
  - 12.6.13.6. Algeria Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
  - 12.6.13.7. Algeria Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
- 12.6.14. Egypt
  - 12.6.14.1. Overview
  - 12.6.14.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 12.6.14.3. Egypt Market Size and Forecast, By Sample Type, 2019 - 2032 (US$ Million)
  - 12.6.14.4. Egypt Market Size and Forecast, By Drug Type, 2019 - 2032 (US$ Million)
  - 12.6.14.5. Egypt Market Size and Forecast, By Test Type, 2019 - 2032 (US$ Million)
  - 12.6.14.6. Egypt Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
  - 12.6.14.7. Egypt Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
- 12.6.15. Rest of MEA
  - 12.6.15.1. Overview
  - 12.6.15.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 12.6.15.3. Rest of MEA Market Size and Forecast, By Sample Type, 2019 - 2032 (US$ Million)
  - 12.6.15.4. Rest of MEA Market Size and Forecast, By Drug Type, 2019 - 2032 (US$ Million)
  - 12.6.15.5. Rest of MEA Market Size and Forecast, By Test Type, 2019 - 2032 (US$ Million)
  - 12.6.15.6. Rest of MEA Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
  - 12.6.15.7. Rest of MEA Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)

13. Key Vendor Analysis- Cytomegalovirus (CMV) Tests Industry

13.1. Competitive Dashboard
13.2. Company Profiles
- 13.2.1. Pfizer Inc.
- 13.2.2. GlaxoSmithKline plc
- 13.2.3. Novartis AG
- 13.2.4. Mylan N.V.
- 13.2.5. Teva Pharmaceutical Industries Ltd.
- 13.2.6. Sanofi
- 13.2.7. F. Hoffmann-La Roche Ltd.
- 13.2.8. Zydus Cadila
- 13.2.9. Lupin
- 13.2.10. Cipla Inc.
- 13.2.11. Aurobindo Pharma
- 13.2.12. Glenmark Pharmaceuticals Limited
- 13.2.13. Endo International plc
- 13.2.14. AstraZeneca
- 13.2.15. Johnson & Johnson Private Limited
- 13.2.16. Bio-Rad Laboratories, Inc.
- 13.2.17. BD
- 13.2.18. Others

14. 360 Degree Analyst View

15. Appendix

15.1. Research Methodology
15.2. References
15.3. Abbreviations
15.4. Disclaimer
15.5. Contact Us